Were the lockdowns a mistake? To that nagging question, the answer increasingly seems to be yes. Certainly, they were a novelty. As novelist Lionel Shriver writes, “We’ve never before responded to a contagion by closing down whole countries.” As I noted in May, the 1957-58 Asian flu killed between 75,000 and 116,000 people in the… Read More: Were the lockdowns a mistake? »
A Covid spike in Bolton and Trafford has prompted council bosses to ask for restrictions to remain in place, a day before they were due to be lifted. Tighter rules were introduced in July in Greater Manchester and parts of Yorkshire after concerns the virus was being spread between households. Bolton currently has one of… Read More: Coronavirus: Bolton and Trafford ask to continue restrictions »
You’d need a pretty big, stiff broom to sweep away all of the hype dished out by the Trump Administration as it announced an Emergency Use Authorization for convalescent plasma – the liquid component of blood that may be tapped for disease-fighting antibodies from people who’ve been infected with COVID-19. Before the announcement was even… Read More: Convalescent plasma: another controversial clash of politics & science »
Amid daily headlines about COVID-19 vaccines and trends, Gilead’s Veklury, also known as remdesivir, remains the only antiviral drug authorized to treat the illness. With a new move from the FDA, the medicine’s emergency green light is a little broader—despite some lingering questions about its efficacy. Under the expanded emergency use authorization (EUA), all hospitalized… Read More: Gilead’s Veklury wins expanded FDA nod for moderate COVID-19 patients… »